In designing and manufacturing therapeutic antibodies, a top objective is precise binding to an intended target. Sometimes, the antibodies can bind to each other through self-association. In a recent ...
SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a ...
At an old biscuit factory in South London, giant mixers and industrial ovens have been replaced by robotic arms, incubators, and DNA sequencing machines. James Field and his company LabGenius aren’t ...
Help build the next generation of AI for antibody discovery. m AIbe is advancing machine‑learning methods at the interface of protein science and therapeutics. We’re looking for a Machine Learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback